Tags

Type your tag names separated by a space and hit enter

What does the Acarbose Cardiovascular Evaluation (ACE) trial tell us?
J Diabetes. 2018 Aug; 10(8):683-685.JD

Links

Publisher Full Text
Aggregator Full Text

Authors+Show Affiliations

Holman RR
Diabetes Trials Unit, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.

MeSH

AcarboseCardiovascular DiseasesDiabetes Mellitus, Type 2Glucose IntoleranceGlycoside Hydrolase InhibitorsHumansTreatment Outcome

Pub Type(s)

Journal Article

Language

eng

PubMed ID

29774661

Citation

Holman, Rury R.. "What Does the Acarbose Cardiovascular Evaluation (ACE) Trial Tell Us?" Journal of Diabetes, vol. 10, no. 8, 2018, pp. 683-685.
Holman RR. What does the Acarbose Cardiovascular Evaluation (ACE) trial tell us? J Diabetes. 2018;10(8):683-685.
Holman, R. R. (2018). What does the Acarbose Cardiovascular Evaluation (ACE) trial tell us? Journal of Diabetes, 10(8), 683-685. https://doi.org/10.1111/1753-0407.12770
Holman RR. What Does the Acarbose Cardiovascular Evaluation (ACE) Trial Tell Us. J Diabetes. 2018;10(8):683-685. PubMed PMID: 29774661.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - What does the Acarbose Cardiovascular Evaluation (ACE) trial tell us? A1 - Holman,Rury R, Y1 - 2018/05/17/ PY - 2018/04/05/received PY - 2018/04/07/accepted PY - 2018/5/19/pubmed PY - 2019/7/13/medline PY - 2018/5/19/entrez SP - 683 EP - 685 JF - Journal of diabetes JO - J Diabetes VL - 10 IS - 8 SN - 1753-0407 UR - https://www.unboundmedicine.com/medline/citation/29774661/What_does_the_Acarbose_Cardiovascular_Evaluation__ACE__trial_tell_us L2 - https://doi.org/10.1111/1753-0407.12770 DB - PRIME DP - Unbound Medicine ER -